Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands

Fig. 1

Patient flow chart showing selection of patients in the PHARMO Database Network Patients in the two study cohorts were matched on clinically and demographically significant characteristics. PHARMO: PHARMO Database Network provided by the PHARMO Institute for Drug Outcomes Research (Utrecht, the Netherlands). ICS: inhaled corticosteroid; initiation date: the date when patients received their first prescription of extrafine-particle ICS (ciclesonide or EF-HFA-BDP), or fine-particle ICS (fluticasone or Non-EF-BDP)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us